CSI
ENOV icon

Cross Staff Investments’s Enovis ENOV Stock Holding History

Cross Staff Investments’s Portfolio ENOV Stock Details ENOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,666
Closed -$229K – 122
2024
Q1 		$229K Hold
3,666
– – 0.19% 110
2023
Q4 		$205K Buy
+3,666
New +$183K 0.18% 112
2023
Q3 		– Sell
-3,666
Closed -$235K – 112
2023
Q2 		$235K Buy
+3,666
New +$209K 0.22% 107
2022
Q1 		– Sell
-2,905
Closed -$230K – 124
2021
Q4 		$230K Buy
+2,905
New +$243K 0.21% 122

Other funds holding ENOV

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return

Cross Staff Investments's ENOV Position: Q2 2024 in Review

Cross Staff Investments sold out of Enovis (ENOV) in Q2 2024, closing a stake of 3,666 shares — an estimated $229K sold.

Cross Staff Investments first reported a position in ENOV in Q4 2021 and held it in 4 quarters. The position peaked at $235K in Q2 2023. 282 funds tracked by Wall St. Rank hold ENOV as of Q2 2024.

  • Cross Staff Investments reported no remaining Enovis position as of Q2 2024 after selling out during the quarter.
  • Cross Staff Investments sold 3,666 Enovis shares in Q2 2024, an estimated $229K.
  • Cross Staff Investments first reported a position in Enovis in Q4 2021 and held it in 4 quarters.
  • Cross Staff Investments's Enovis position peaked at $235K in Q2 2023.
  • 282 funds tracked by Wall St. Rank held Enovis as of Q2 2024.

Based on Cross Staff Investments's 13F filing for Q2 2024, filed 6 Aug 2024.